The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Open accessAbstract
Resistance to the limited number of available antifungal drugs is a serious problem in the treatment of Candida albicans . We found that aneuploidy in general and a specific segmental aneuploidy, consisting of an isochromosome composed of the two left arms of chromosome 5, were associated with azole resistance. The isochromosome forms around a single centromere flanked by an inverted repeat and was found as an independent chromosome or fused at the telomere to a full-length homolog of chromosome 5. Increases and decreases in drug resistance were strongly associated with gain and loss of this isochromosome, which bears genes expressing the enzyme in the ergosterol pathway targeted by azole drugs, efflux pumps, and a transcription factor that positively regulates a subset of efflux pump genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Copy number variations, including whole-chromosome aneuploidy and shorter-range amplifications, are genome changes that can increase resistance32,43–49.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [44]
In the citing paper
“By altering gene dosage or expression levels, aneuploidy allows fungi to quickly adjust to adverse conditions without permanent genetic mutations, promoting survival in fluctuating environments [99,129,145,152,154].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [129]
In the citing paper
“Associated resistance is mainly related to chr5, which has the ERG11 and TAC1 gene [129,130].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [129]
In the citing paper
“By increasing the copy number of chromosomes containing drug resistance genes, such as those encoding transcription factors, efflux pumps or involved in ergosterol biosynthesis, aneuploidy leads to resistance against multiple antifungals. including azoles and echinocandins [99,129,154].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [129]
In the citing paper
“Alternatively, instances of aneuploidy, specifically, chromosome 5 duplication or chr5L isochromosome formation, are known mechanisms of ERG11 overexpression in C. albicans (29).”
From Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans (2012) · cites this paper as [29]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Widespread aneuploidy revealed by DNA microarray expression profiling
Hughes, T. R., Roberts, C. J., Dai, H., Jones, A. R., Meyer, M. R., Slade, D., Burchard, J., Dow, S., Ward, T. R., Kidd, M. J., et al. (2000) · Nature Genetics · doi:10.1038/77116 · Cited by 482
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407
Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385
Self-citationBennett, R. J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg235 · Cited by 341
Determining centromere identity: cyclical stories and forking paths
Sullivan, B. A., Blower, M. D., & Karpen, G. H. (2001) · Nature Reviews Genetics · doi:10.1038/35084512 · Cited by 283
Evolution of Drug Resistance in Experimental Populations of Candida albicans
Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., & Kohn, L. M. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.6.1515-1522.2000 · Cited by 207
Janbon, G., Sherman, F., & Rustchenko, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5150 · Cited by 202
Centromeric DNA sequences in the pathogenic yeast Candida albicans are all different and unique
Sanyal, K., Baum, M., & Carbon, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404318101 · Cited by 180
Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5601-5613.2005 · Cited by 178
Marr, K. A., Lyons, C. N., Rustad, T., Bowden, R. A., & White, T. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2584 · Cited by 166
Replication Forks Pause at Yeast Centromeres
Greenfeder, S. A., & Newlon, C. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4056-4066.1992 · Cited by 163
Karababa, M., Coste, A. T., Rognon, B., Bille, J., & Sanglard, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3064-3079.2004 · Cited by 161
Selmecki, A., Bergmann, S., & Berman, J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04492.x · Cited by 157
Self-citationAnderson, J. B., Sirjusingh, C., Parsons, A. B., Boone, C., Wickens, C., Cowen, L. E., & Kohn, L. M. (2003) · Genetics · doi:10.1093/genetics/163.4.1287 · Cited by 156
Marr, K. A., White, T. C., van Burik, J. H., & Bowden, R. A. (1997) · Clinical Infectious Diseases · doi:10.1086/515553 · Cited by 145
Construction of an SfiI macrorestriction map of the Candida albicans genome
Chu, W., Magee, B. B., & Magee, P. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.20.6637-6651.1993 · Cited by 141
Cowen, L. E., Kohn, L. M., & Anderson, J. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.2971-2978.2001 · Cited by 117
Chromosome 1 trisomy compromises the virulence of Candida albicans
Chen, X., Magee, B. B., Dawson, D., Magee, P. T., & Kumamoto, C. A. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03852.x · Cited by 103
Schönian, G., Meusel, O., Tietz, H., Meyer, W., Gräser, Y., Tausch, I., Presber, W., & Mitchell, T. G. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00746.x · Cited by 92
Chromosomal Translocation and Segmental Duplication in Cryptococcus neoformans
Fraser, J. A., Huang, J. C., Pukkila-Worley, R., Alspaugh, J. A., Mitchell, T. G., & Heitman, J. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.2.401-406.2005 · Cited by 90
Genetic Structure of Typical and Atypical Populations of Candida albicans from Africa
Forche, A., Schönian, G., Gräser, Y., Vilgalys, R. J., & Mitchell, T. G. (1999) · Fungal Genetics and Biology · doi:10.1006/fgbi.1999.1164 · Cited by 78
Self-citationReversible fluconazole resistance in Candida albicans: a potential in vitro model
Calvet, H. M., Yeaman, M. R., & Filler, S. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.535 · Cited by 75
Effect of the Major Repeat Sequence on Chromosome Loss in Candida albicans
Lephart, P., Chibana, H., & Magee, P. T. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.733-741.2005 · Cited by 49
Research works printed but not linked: 2
- S. A. Greenfeder, C. S. Newlon, Mol. Cell. Biol.12, 4056 (1992).
- We thank J. Anderson P. T. Magee P. D. Rogers D. Sanglard and T. White for providing strains and M. Gerami-Nejad M. McClellan M. Carlson and J. Borton for technical assistance. We thank A. Nantel M. van het Hoog and P. T. Magee for genome map information; S. Bergmann for Chromosome_Map programming; and N. Springer D. Kirkpatrick J. Strathern M. Kupiec M. Basrai and D. Sanglard for helpful discussions and review of the manuscript. This work was supported by NIH R01 AIO62427 to J.B. a Microbial and Plant Genomics Institute Integrative fellowship to A.S. and a microarray supplemental award DE10641-S to M. Edgerton. Sequence analysis of chr5 is deposited in GenBank accession number DQ660981. The CGH array data are listed in GEO the Gene Expression Omnibus as series “CGH analysis of Candida albicans strains” with accession number GSE4995.
Cited by
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Self-citationThe global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
“Aneuploidy plays a role in azole resistance in C. albicans as demonstrated by comparative genome hybridization (Selmecki et al., 2006).”
BackgroundCauses and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Metadata
- Authors
- Selmecki, A., Forche, A., & Berman, J.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Berman, Judith
- Venue
- Science
- Published
- 2006-07-21
- Volume
- 313
- Issue
- 5785
- Pages
- 367-370
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC1717021
- OpenAlex
- W2091902964
- Cited by
- 733
- References
- 26
- Citations by year
- 2026: 33 · 2025: 40 · 2024: 48 · 2023: 38 · 2022: 35 · 2021: 55 · 2020: 39 · 2019: 50 · 2018: 35 · 2017: 45 · 2016: 35 · 2015: 46 · 2014: 43 · 2013: 32 · 2012: 39
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Bowdoin - Digital Commons (Bowdoin College) (submittedVersion)
- Funders
- U.S. Public Health Service (R01 AIO62427)
- National Institute of Allergy and Infectious Diseases (R01AI062427)
- National Institute of Dental and Craniofacial Research (DE10641-S)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, aneuploidy, isochromosomes, segmental aneuploidy, azole resistance, antifungal resistance, chromosome 5, ergosterol biosynthesis, efflux pumps, transcription factors, inverted repeats, telomere fusion
- MeSH terms
- Aneuploidy, Antifungal Agents, Azoles, Candida albicans, Centromere, Cytochrome P-450 Enzyme System, Ergosterol, Fungal Proteins, Genes, Fungal, Karyotyping, Molecular Sequence Data, Repetitive Sequences, Nucleic Acid, Transcription Factors, Trisomy, Fluconazole, Chromosomes, Fungal, Sequence Analysis, DNA, Isochromosomes, Gene Dosage, Gene Expression Profiling, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.